Expanding hepatitis C virus (HCV) testing and treatment to people with a history of incarceration is critical to ending San Francisco’s HCV epidemic. HCV testing and treatment for people who are incarcerated in county jails is uniquely challenging, as the rapid cycles of arrest and release create a dynamic population, including many people with short-term stays. In 2025, End Hep C SF, San Francisco’s collective impact initiative focused on HCV elimination, hired Facente Consulting to lead an assessment of HCV treatment opportunities in county jails, focusing on short-stay clients who spend less than four weeks in jail.
In this project, Facente Consulting will analyze secondary data to understand the volume and characteristics of short-stay jail clients, including outcomes related to HCV testing and treatment in jail and HCV treatment post-release. Facente Consulting will also interview Jail Health Services staff, staff from agencies focused on supporting the health of people who have been incarcerated, and people living with HCV who were formerly incarcerated for a short jail stay. Facente Consulting will present findings from this assessment to the End Hep C SF Treatment Access workgroup and Prevention, Testing, & Linkage workgroup to discuss findings and gather feedback on the types of targeted interventions that can improve the HCV care cascade for people with short-term jail stays.